It is not a generic or substitute, it is the same molecule, tirzepatide, formulated and dispensed under medical supervision
The combination works to keep the skin feeling firm, moisturized, and balanced throughout daily use
However Lillys demonstration that a GIP/GLP-1 receptor co-agonist (tirzepatide) has superior efficacy compared to selective GLP-1 receptor agonists, has renewed interest in the first incretin. Lilly rolled out their SURPASS trials to position their agent amongst existing diabetes medications and GLP-1 agonists
A low carb diet supports: Fat loss Blood sugar control Muscle preservation Improved satiety Reduced cravings Long-term weight maintenance By focusing on protein, nutrient density, hydration, and supportive low carb products, GLP-1 users can transform short-term weight loss into lasting health
in vitro -
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications